ASX Announcement Receipt of notice under section 249N Sydney Australia, 29 September 2026: Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) (Recce or the Company) advises, in accordance with ASX Listing Rule 3.17A, that on 25 September 2026 it received a notice stated to be given under section...